Featured Research

from universities, journals, and other organizations

Unique omega-3 supplement effective at reducing exercise-induced asthma symptoms

Date:
May 28, 2013
Source:
Indiana University
Summary:
A new study found that an omega-3 supplement derived from the New Zealand green-lipped mussel improved lung function and reduced airway inflammation in asthmatics with exercise-induced asthma.

An Indiana University study has found that a unique omega-3 supplement derived from the New Zealand green-lipped mussel significantly improved lung function and reduced airway inflammation in asthmatics who experience exercise-induced bronchoconstriction, also called exercise-induced asthma.

Timothy Mickleborough, professor in the IU School of Public Health-Bloomington, said his findings are similar to his studies involving fish oil but required a much smaller dosage of the supplement. His new study, appearing online in the journal Respiratory Medicine, found a 59 percent improvement in lung function after an airway challenge, and a reduction in airway inflammation, asthma symptoms and use of emergency medication.

"Not only does it reduce symptoms, which will make you feel better, but it potentially could improve athletic performance," Mickleborough said. "Any time you can reduce medication is good."

In exercise-induced asthma, vigorous exercise triggers an acute narrowing of the airway afterward, making breathing difficult. Other symptoms include coughing, tightening of the chest and excessive fatigue. About 90 percent of people with asthma have this condition, which also is found in an estimated 10 percent or more of elite athletes and as much as 10 percent of the general population without asthma.

Mickleborough's study used Lyprinol/Omega XL, which contains PCSO-524, a patented extract of stabilized lipids from the New Zealand green-lipped mussel, combined with olive oil and vitamin E. PCSO-524 includes the five main lipid classes: sterol esters, sterols, polar lipids, triglycerides and free fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Previous studies involving PCSO-524 have found it to be effective in treating osteoarthritis, rheumatoid arthritis and inflammatory bowel disease. Mickleborough's study is the first to show that it is effective in reducing the airway inflammation experienced by asthmatic study participants diagnosed with exercise-induced asthma.

Mickleborough is chairing a symposium, "Health and Performance Benefits of Omega-3 Fatty Acids: Something Fishy Going On?" at 9 a.m. Saturday at the American College of Sports Medicine annual meeting in Indianapolis. Results from his PCSO-524 study will be discussed at the meeting during a poster session at 8-9:30 a.m. on Thursday.

About the study:

*The study involved 12 men and eight women ages 20 to 24 and was conducted in the Human Performance and Exercise Biochemistry Laboratory in the Department of Kinesiology at IU. All study participants had physician-diagnosed asthma and documented exercise-induced asthma. The study was conducted as a randomized, double-blind, placebo-controlled crossover trial. Study participants, none of whom took daily maintenance medication but all of whom used rescue inhalers, followed their regular diet for three weeks. Then, half took a placebo for three weeks while the rest took the supplement. They then followed their normal diet for two weeks. After that, they took the alternative supplement for three weeks. The placebo and PCSO-524 looked identical. A eucapnic voluntary hyperventilation challenge, which is a scientifically preferred substitute for an exercise challenge, was conducted at the beginning of the study and after each treatment period. Various measures of lung function and inflammation were collected before and after the eucapnic voluntary hyperventilation challenge, and study participants were asked to keep track of emergency inhaler use, symptoms and peak flow measurements.

Mickleborough plans to conduct further studies that look at the impact of PCSO-524 on delayed onset muscle soreness and delayed onset muscle damage. He also will examine whether the supplement can improve lung function and relieve airway inflammation in elite athletes who do not have asthma.

The research for "Marine lipid fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma," was supported by a grant from Pharmalink International LTD, which manufactures and owns PCSO-524. The funder had no role in study design, data collection and analysis, in writing the journal article, or the decision to publish.

Co-authors include Cherissa L. Vaughn, Ren-Jay Shei, Eliza M. Davis and Daniel P. Wilhite, all with the Department of Kinesiology in the IU School of Public Health-Bloomington.


Story Source:

The above story is based on materials provided by Indiana University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Timothy D. Mickleborough, Cherissa L. Vaughn, Ren-Jay Shei, Eliza M. Davis, Daniel P. Wilhite. Marine lipid fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Respiratory Medicine, 2013; DOI: 10.1016/j.rmed.2013.04.010

Cite This Page:

Indiana University. "Unique omega-3 supplement effective at reducing exercise-induced asthma symptoms." ScienceDaily. ScienceDaily, 28 May 2013. <www.sciencedaily.com/releases/2013/05/130528105241.htm>.
Indiana University. (2013, May 28). Unique omega-3 supplement effective at reducing exercise-induced asthma symptoms. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/05/130528105241.htm
Indiana University. "Unique omega-3 supplement effective at reducing exercise-induced asthma symptoms." ScienceDaily. www.sciencedaily.com/releases/2013/05/130528105241.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins